Try our Advanced Search for more refined results

March 29, 2018

IN RE CELGENE CORPORATION, INC. SECURITIES LITIGATION

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 26, 2020

    Celgene Fights Investors' Class Cert. Bid In Stock-Drop Suit

    Celgene Corp. Inc. is urging a New Jersey federal court to reject a Swedish investor's bid to certify a proposed class action claiming the biopharmaceutical company artificially inflated its share price by concealing timeline and growth problems with two of its drugs, arguing that certain alleged misstatements were made after the stock was purchased.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!